IQVIA

Iqvia beats Street earnings expectations but revenues miss

Posted by WRAL TechWire | Nov 1, 2023

Iqvia’s results surpassed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $2.46 per share.

Life science giant Iqvia names new leader for R&D solutions

Posted by WRAL TechWire | Sep 26, 2023

Iqvia has a new lead for research and development solutions, but he’s a familiar face. Here are the details.

Iqvia CEO touts ‘strong operational and financial results’

Posted by WRAL TechWire | Aug 1, 2023

Life science giant Iqvia on Tuesday reported second-quarter financials that topped Wall Street expectations. We’ve got the details.

Judge delays data ‘juggernaut’ Iqvia’s big digital media acquisition in FTC fight

Posted by WRAL TechWire | Jul 26, 2023

Life science giant Iqiva’s bid to deepen its grip on programmatic advertising in the healthcare market has been put on hold until at least November by a district court judge.

Feds move to block life science giant Iqvia’s acquisition of digital media firm

Posted by WRAL TechWire | Jul 18, 2023

Life science giant Iqvia’s plans to acquire digital media company Propel Media face a big hurdle: The Federal Trade Commission voted 3-0 Monday to seek to block the merger.

Iqvia went to Street to raise $1B – it lands even more

Posted by WRAL TechWire | May 19, 2023

Iqvia disclosed plans earlier this week to raise $1 billion. It then went to market. End result: $1.25B. But the money didn’t come cheaply.

Life science giant Iqvia says it’s looking to raise $1 billion

Posted by WRAL TechWire | May 18, 2023

Iqvia is looking to raise $1 billion, the life science giant announced Thursday. But the company apparently doesn’t have big plans for cash such as a merger or acquisition.

Reports: FTC mulls block of Iqvia deal to buy digital ad specialist firm for up to $800M

Posted by WRAL TechWire | May 12, 2023

Triangle-based Iqvia, a giant in the life science sector, is facing increasing scrutiny from the Federal Trade Commission over its proposed buy of Propel Media, the owner of DeepIntent which focuses on digital advertising, according to reports in Politico and Fierce Pharma Marketing.